Conference Coverage

This symptom signals UTI in 83% of cases


 

TOPLINE:

Dyspareunia is a major indicator of urinary tract infections, being present in 83% of cases. The symptom is especially accurate at identifying UTIs in nonmenopausal women, researchers have found.


METHODOLOGY:

  • Dyspareunia is a common symptom of UTIs, especially in premenopausal women, but is rarely inquired about during patient evaluations, according to researchers from Florida Atlantic University.
  • In 2010, the researchers found that among 3,000 of their female Latinx patients aged 17-72 years in South Florida, 80% of those with UTIs reported experiencing pain during sexual intercourse.
  • Since then, they have studied an additional 2,500 patients from the same population.

TAKEAWAY:

  • Among all 5,500 patients, 83% of those who had UTIs experienced dyspareunia.
  • Eighty percent of women of reproductive age with dyspareunia had an undiagnosed UTI.
  • During the perimenopausal and postmenopausal years, dyspareunia was more often associated with genitourinary syndrome than UTIs.
  • Ninety-four percent of women with UTI-associated dyspareunia responded positively to antibiotics.

IN PRACTICE:

“We have found that this symptom is extremely important as part of the symptomatology of UTI [and is] frequently found along with the classical symptoms,” the researchers reported. “Why has something so clear, so frequently present, never been described? The answer is simple: Physicians and patients do not talk about sex, despite dyspareunia being more a clinical symptom than a sexual one. Medical schools and residency programs in all areas, especially in obstetrics and gynecology, urology, and psychiatry, have been neglecting the education of physicians-in-training in this important aspect of human health. In conclusion, this is [proof] of how medicine has sometimes been influenced by religion, culture, and social norms far away from science.”

SOURCE:

The data were presented at the 2023 meeting of the Menopause Society. The study was led by Alberto Dominguez-Bali, MD, from Florida Atlantic University, Boca Raton, Fla.

LIMITATIONS:

The study authors reported no limitations.

DISCLOSURES:

The authors reported no relevant financial relationships.

A version of this article first appeared on Medscape.com.

Recommended Reading

Hormone therapies still ‘most effective’ in treating menopausal vasomotor symptoms
MDedge Endocrinology
A new nonhormonal option for menopausal hot flashes: What prescribers should know
MDedge Endocrinology
A ‘one-stop shop’: New guidance on hormones and aging
MDedge Endocrinology
Does ‘skeletal age’ describe fracture impact on mortality?
MDedge Endocrinology
HT, even short-term use, linked to dementia risk in women
MDedge Endocrinology
Progesterone might benefit women in perimenopause
MDedge Endocrinology
Underprescribed menopause relief: Women suffer needlessly
MDedge Endocrinology
PCPs facing increased patient demand for knowledgeable menopause care
MDedge Endocrinology
Premenstrual disorders may be preview of early menopause
MDedge Endocrinology
Hormone replacement therapy for postmenopausal osteoporosis
MDedge Endocrinology